Genoray KRX:122310KOSDAQ
제노레이 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days0
DART filings, 7 days1
Articles tracked3since Sep 11
In Q2 2026, Genoray reported revenue of ₩26.6bn, down 1.4% year on year, and operating profit of ₩249m. Genoray (제노레이) appeared in 0 Korean news articles and 1 DART filing over the past seven days.
Filing signals Turnaround Insider buying Dividend cut Share pledge Screener
Genoray quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩26.6bn | -1.4% | ₩249m margin 0.9% | ₩608m |
| Q1 2026 | ₩25.4bn | +0.9% | −₩1.6bn margin −6.2% | −₩429m |
| Q4 2025 derived | ₩34.0bn | +18.4% | ₩1.4bn margin 4.1% | ₩3.4bn |
| Q3 2025 | ₩21.8bn | -8.9% | −₩1.7bn margin −7.6% | −₩1.0bn |
| Q2 2025 | ₩27.0bn | -7.6% | −₩36m margin −0.1% | −₩1.8bn |
| Q1 2025 | ₩25.2bn | +0.5% | ₩78m margin 0.3% | ₩93m |
| Q4 2024 derived | ₩28.8bn | -6.5% | −₩99m margin −0.3% | −₩6.2bn |
| Q3 2024 | ₩24.0bn | +2.3% | ₩1.0bn margin 4.3% | ₩424m |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.
Genoray top stories 2 weeks, by number of outlets
No story covered by multiple outlets in the past two weeks.